Founder of Aurora Cannabis Terry Booth, Joins Akanda as Chair of Advisory Board
September 08 2022 - 7:31AM
Business Wire
Proven Global Cannabis Executive Joins to Help
Guide Akanda’s European Strategy
International cannabis company Akanda Corp. ("Akanda" or the
“Company”) (NASDAQ: AKAN) today announced that Terry Booth, the
founder of Aurora Cannabis Inc. (“Aurora Cannabis”) (NASDAQ:ACB)
has joined Akanda as a Chair of Akanda’s newly formed Advisory
Board.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220908005613/en/
Akanda today announced that Terry Booth,
the founder of Aurora Cannabis Inc. (“Aurora Cannabis”)
(NASDAQ:ACB) has joined Akanda as a Chair of Akanda’s newly formed
Advisory Board. (Photo: Business Wire)
Terry Booth was an original founder of Aurora Cannabis. He
raised Aurora from its infancy into one of the world’s largest and
fastest growing cannabis companies with a market cap over $16
billion, with a focus on providing high-quality medical and adult
use cannabis, and spearheaded the development of the first in the
world 100% EU GMP certified medical cannabis production facility in
Mountain View County, Alberta. He has a deep knowledge of highly
regulated environments and has assembled and led diverse and
highly-skilled team of experts from a broad range of disciplines to
execute global cannabis business strategies. He has successfully
made and integrated over 30 acquisitions and transactions in the
last five years and has served as President/CEO of six other highly
successful companies, such as Superior Safety Codes, which was
recognized as one of Canada’s top 50 fastest-growing companies by
Mclean Business magazine.
“Terry is an iconic figure in the regulated cannabis industry,
having founded and led Aurora, he contributes his wide-range
expertise to a of rapidly growing organizations around the globe,”
commented Akanda’s CEO Tej Virk. “Having Terry on board as an
advisor is a powerful validation of our strategy and our potential
to lead the emerging cannabis market in Europe. I look forward to
his guidance as we continue to build out our European seed to
patient mode.”
“I believe that there is significant potential in Akanda and I
see similarities to it and when we were at Aurora in the stages
before our explosive growth. Akanda stands out as one of the best
positioned companies focused on the emerging European cannabis
market, which makes joining Akanda as an advisor an easy decision
for me,” commented Mr. Booth. “Not only does Akanda have terrific
assets, including one of the larger EU GMP indoor facilities in the
European Union, but it is blessed with a local team that knows the
market well and has proven experience scaling medical cannabis
operations in Europe. I am looking forward to advising Tej and the
rest of the team in Europe.”
About Akanda Corp.
Akanda is an international medical cannabis and wellness
platform company seeking to help people lead better lives through
improved access to high quality and affordable products. Akanda’s
portfolio includes Holigen, a Portugal-based cultivator,
manufacturer and distributor with a prized EU GMP certified indoor
grow facility; CanMart, a UK-based fully licensed pharmaceutical
importer and distributor which supplies pharmacies and clinics
within the UK; and Bophelo Bioscience & Wellness, a GACP
qualified cultivation campus in the Kingdom of Lesotho in Southern
Africa. The Company’s seed-to-patient supply chain also includes
partnerships with Cellen Life Sciences’ Leva Clinic, one of the
first fully digital pain clinics in the UK, and Cansativa GmbH, a
leading distributor of medical cannabis in Europe.
Connect with Akanda: Website | LinkedIn | Twitter |
Instagram
Cautionary Note Regarding Forward-Looking Information and
Statements
This press release contains certain "forward-looking
information" within the meaning of applicable Canadian securities
legislation and may also contain statements that may constitute
"forward-looking statements" within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Such forward-looking information and
forward-looking statements are not representative of historical
facts or information or current condition, but instead represent
only Akanda's beliefs regarding future events, plans or objectives,
many of which, by their nature, are inherently uncertain and
outside of Akanda's control. Generally, such forward-looking
information or forward-looking statements can be identified by the
use of forward-looking terminology such as "plans," "expects" or
"does not expect," "is expected," "budget," "scheduled,"
"estimates," "forecasts," "intends," "anticipates" or "does not
anticipate," or "believes," or variations of such words and phrases
or may contain statements that certain actions, events or results
"may," "could," "would," "might" or "will be taken," "will
continue," "will occur" or "will be achieved". Forward-looking
information may relate to anticipated events or results including,
but not limited to business strategy, product development and sales
and growth plans. The forward-looking information and
forward-looking statements contained in this press release are made
as of the date of this press release, and Akanda does not undertake
to update any forward-looking information and/or forward-looking
statements that are contained or referenced herein, except in
accordance with applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220908005613/en/
Investors
Matt Chesler, CFA FNK IR ir@akandacorp.com
Media
Imogen Saunders Irvine Partners imogen@irvinepartners.co.uk
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Sep 2023 to Sep 2024